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Correction to: British Journal of Cancer (2008) 98, 571–579.
doi:10.1038/sj.bjc.6604181
The authors wish to add an acknowledgement to their paper,
recently published online (AOP) and in this issue.
The final sentence of the Acknowledgements section should now
read (additional acknowledgement in bold):
‘This work was supported by Breast Cancer Campaign (FD and
EK), Breast Cancer Research Trust (MS, G-XK and EK), Medical
Research Council (DF and EK), Research Promotion Fund from
the University of Essex (FD, IC and EK) and by the Intramural
Research Program of the National Institutes of Health, National
Institute of Allergy and Infectious Diseases (ZKA, SP and VL);V D
was supported by a PhD studentship from the BBSRC, UK; NP is
Clinical Fellow supported by the Essex Rivers NHS Trust’.
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